Related Experiment Video
Updated: May 15, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Synchronous Ampullary Adenocarcinoma and Renal Cell Carcinoma: A Rare Case Report and Literature Review
Thang Manh Hoang1,2,3, Noi Xuan Bui1, Viet Xuan Nghiem4
1Vietnam National Cancer Hospital, Hanoi, Vietnam.
Introduction:
Synchronous multiple primary malignancies represent a complex oncological phenomenon with significant clinical implications. The concurrent presentation of ampullary adenocarcinoma and renal cell carcinoma (RCC) constitutes an exceptionally rare clinical entity, with minimal documented cases globally and no previous reports from Vietnam. This study examines the epistemological and therapeutic dimensions of this rare oncological convergence.
Case Presentation:
We present a comprehensive analysis of a 66-year-old male with synchronous ampullary adenocarcinoma and RCC. The patient presented with right upper quadrant pain, and diagnostic evaluation revealed a 14 × 16 mm ampullary lesion and a 42 × 44 mm right upper pole renal mass. Following multidisciplinary consultation, the patient underwent combined pancreaticoduodenectomy, right nephrectomy, and lymphadenectomy. Histopathological examination confirmed ampullary adenocarcinoma in situ and grade 2 clear cell RCC. The patient's postoperative course was uneventful, with preserved functional status at 9-month follow-up.
Conclusion:
The synchronous occurrence of ampullary adenocarcinoma and RCC presents substantial diagnostic and therapeutic challenges. This first documented Vietnamese case demonstrates the feasibility of curative surgical intervention despite the technical complexity involved, emphasizing the importance of integrated multidisciplinary management in optimizing outcomes for patients with rare synchronous malignancies.
